05/01/2024
6:15 PM | Aileron Therapeutics (Issuer)
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/01/2024
4:24 PM | Aileron Therapeutics (Filer)
| Form 424B5 | |
05/01/2024
4:25 PM | Aileron Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/01/2024
4:16 PM | Aileron Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
05/01/2024
7:40 AM | Aileron Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/01/2024
7:54 AM | Aileron Therapeutics (Subject)
| Form FWP | |
04/30/2024
2:32 PM | Aileron Therapeutics (Issuer)
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
|
04/29/2024
7:33 AM | Aileron Therapeutics (Filer)
| Form 10-K/A | |
04/16/2024
4:16 PM | Aileron Therapeutics (Subject)
Satter Muneer A (Filed by)
| Form SC 13D/A | |
04/15/2024
4:21 PM | Aileron Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
04/15/2024
4:22 PM | Aileron Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/10/2024
3:15 PM | Aileron Therapeutics (Issuer)
Ambros Reinhard J. (Reporting)
| Form 4/A | |
04/10/2024
3:15 PM | Aileron Therapeutics (Issuer)
VON RICKENBACH JOSEF H (Reporting)
| Form 4/A | |
04/02/2024
5:10 PM | Aileron Therapeutics (Issuer)
Garner Charles (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
04/01/2024
3:15 PM | Aileron Therapeutics (Filer)
| Form NT 10-K | |
03/29/2024
7:03 AM | Aileron Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/15/2024
6:00 AM | Aileron Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/06/2024
4:06 PM | Aileron Therapeutics (Issuer)
WINDSOR JAMES BRIAN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
6:14 PM | Aileron Therapeutics (Subject)
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGMENT CO (Filed by)
| Form SC 13G | |
03/01/2024
3:05 PM | Aileron Therapeutics (Issuer)
VON RICKENBACH JOSEF H (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2024
3:05 PM | Aileron Therapeutics (Issuer)
Ambros Reinhard J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
6:01 AM | Aileron Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
9:28 AM | Aileron Therapeutics (Subject)
BIOTECHNOLOGY VALUE FUND L P (Filed by)
| Form SC 13G/A | |
02/13/2024
6:01 AM | Aileron Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/05/2024
11:15 PM | Aileron Therapeutics (Filer)
| Form EFFECT | |
02/05/2024
12:20 PM | Aileron Therapeutics (Subject)
Kapnick Scott (Filed by)
| Form SC 13G/A | |
01/29/2024
7:46 AM | Aileron Therapeutics (Filer)
| Form DEF 14A | |
01/29/2024
7:48 AM | Aileron Therapeutics (Filer)
| Form ARS | |
01/29/2024
7:14 AM | Aileron Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/25/2024
6:00 AM | Aileron Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/19/2024
3:44 PM | Aileron Therapeutics (Filer)
| Form PRE 14A | |
01/11/2024
3:18 PM | Aileron Therapeutics (Filer)
| Form 8-K/A | |
01/10/2024
3:08 PM | Aileron Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/18/2023
4:56 PM | Aileron Therapeutics (Issuer)
WINDSOR JAMES BRIAN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/21/2023
3:43 PM | Aileron Therapeutics (Issuer)
WINDSOR JAMES BRIAN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/16/2023
7:05 AM | Aileron Therapeutics (Filer)
| Form D
Notice of Exempt Offering of Securities | |
11/13/2023
4:08 PM | Aileron Therapeutics (Subject)
BIOS Fund I, LP (Filed by)
| Form SC 13G | |
11/02/2023
7:51 PM | Aileron Therapeutics (Issuer)
Musso Alan A (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
11/02/2023
7:53 PM | Aileron Therapeutics (Issuer)
Musso Alan A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/02/2023
7:55 PM | Aileron Therapeutics (Issuer)
Fairey William (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/02/2023
7:47 PM | Aileron Therapeutics (Issuer)
WINDSOR JAMES BRIAN (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
Never use this word on your phone (FBI could be watching) (Ad) This report sent a chill down my spine.
Turns out, as part of their Jan. 6th investigation, the Feds are flagging Americans who typed these ordinary words as part of their banking transactions... Watch my unredacted video about what I think is coming next right here |
11/02/2023
7:50 PM | Aileron Therapeutics (Issuer)
Fairey William (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
10/31/2023
11:40 AM | Aileron Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/13/2023
3:05 PM | Aileron Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/11/2023
3:05 PM | Aileron Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/08/2023
7:00 AM | Aileron Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
